Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial Meeting Abstract


Authors: Staehler, M.; Motzer, R. J.; George, D. J.; Pandha, H. S.; Donskov, F.; Escudier, B.; Kliment, J.; Pantuck, A. J.; Patel, A.; Deannuntis, L.; Bhattacharyya, H.; Lin, X.; Lechuga, M.; Serfass, L.; Patard, J. J.; Ravaud, A.
Abstract Title: Adjuvant sunitinib (SU) in patients (pts) with high risk renal cell carcinoma (RCC): Safety and therapy management in S-TRAC trial
Meeting Title: 42nd ESMO Congress (ESMO 2017)
Journal Title: Annals of Oncology
Volume: 28
Issue: Suppl. 5
Meeting Dates: 2017 Sep 8-12
Meeting Location: Madrid, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2017-09-01
Start Page: mdx371.009
Language: English
ACCESSION: WOS:000411324002045
PROVIDER: wos
DOI: 10.1093/annonc/mdx371.009
Notes: Meeting Abstract: 855PD -- Appears on page 300 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1243 Motzer